Grail (GRAL) Stock Price

Grail Price

NYSE·CLOSED
143.26
​
Market closed

Over the last 4 years Grail grew revenue by 78.1% annually, reaching 147.17 M USD. For Grail, the net margin of -277.5% is up versus -8,539.4% a few years ago. The consensus 12-month price target for Grail is 62.50 USD, about 56.4% below where the stock trades today. Of 15 analysts, 9 rate the stock a buy — an overall Buy consensus.

Grail stock price

Access this data via the Eulerpool API

Grail business model & stock analysis

Grail Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Menlo Park, California and currently employs 1,340 full-time employees. The company went IPO on 2024-06-12. GRAIL, Inc., formerly GRAIL, LLC, is a healthcare company, which is engaged in saving lives and shifting the paradigm in early cancer detection. The company is focused on alleviating the global burden of cancer by using next-generation sequencing, population-scale clinical studies, and machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. Its targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. Its products include Galleri and Beyond. The Galleri test is a commercially available screening test for early detection of multiple types of cancer, which is termed multi-cancer early detection (MCED). Galleri screening test results can help guide next steps for a diagnosis of cancer by healthcare providers.

Frequently asked questions about Grail

Analysts currently set an average price target of 65.17 USD for the Grail stock (median: 62.50 USD), implying -54.5 % versus the latest price. The consensus is based on 15 analyst ratings.

15 analysts currently rate the Grail stock: 9 recommend buying, 6 holding and 0 selling. For 2026, analysts expect Grail to generate revenue of 180.80 M USD and earnings per share of -9.21 USD.

Converted at the current exchange rate, the Grail share trades at 127.34 EUR (143.26 USD).

The expected revenue of Grail is 180.80 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Grail is -374.91 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Grail is currently -15.56. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Grail stock.

The price-to-sales ratio (P/S) of Grail is currently 32.27. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Grail stock.

The Eulerpool Quality Score for Grail is 3/10.

The ISIN of Grail is US3847471014. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Grail is GRAL. The ticker symbol is used to trade Grail shares on the stock exchange.

Fair ValueTerminal
124.64 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue per Employee
161,727.47 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website galleri.com
Currency
USD
Initial public offering
Jun 12, 2024
ISIN
US3847471014
Cusip
384747101
Market capitalization
5.58 B USDMid Cap
52-Week Range
Revenue growth (10Y) > 5%
Revenue growth (3Y) > 5 %
EBIT growth (10Y) > 5%
EBIT growth (3Y) > 5 %
Net debt < 4x EBIT
Profitable since 10Y+
EBIT Drawdown (10Y) < 50%
Return on Equity (ROE) > 15%
ROCE > 15%
Return Expectation > 10%
PEG
12.56
P/E ratio
P/Ee 2026
-15.56
P/Ee 2027
-14.69
P/Ee 2028
-15.49
P/Ee 2029
-14.79
P/Ee 2030
-16.48
P/Se
32.27
EV/EBIT
—
P/B Ratio
2.17
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-15.77 %
Gross Margin
-42.52 %
EBIT Margin
-362.95 %
Net Margin
-277.47 %
EPS (Earnings Per Share)
-10.03 USD
Net Debt / EBIT
0.45
Debt/Equity
0.00
Last updated Oct 5, 2026, 6:03 AM

Grail Peer Group

All fundamentals and in-depth analysis of Grail

Our stock analysis for Grail stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Grail. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.